Riskpilot← Back to searchSign inGet full accessTM TECHNOLOGIES AS
ASActiveOrg 918672931Drammensveien 167, 0277 OsloResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20171 employees
Revenue 2024
NOK 0
EBITDA margin
—
+96% vs 2023
Equity ratio
99.9%
Financial strength
Net profit 2024
NOK -222K
+95% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -205K | +96% |
| Net profit | NOK -222K | +95% |
| Total assets | NOK 1,7M | -35% |
| Equity | NOK 1,7M | -12% |
| Employees | 1 | — |
Legal name
TM TECHNOLOGIES AS
Org number
918672931
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
8. mars 2017
Share capital
NOK 128 346
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Utvikling og salg av isotoper til medisinsk industri.
Address
Drammensveien 167, 0277 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 53 | 0 | 63 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −964 | −1 264 | −1 533 | −1 701 | −1 619 | −1 197 | −4 820 | −205 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −14 | −56 |
| EBIT | −964 | −1 264 | −1 533 | −1 701 | −1 619 | −1 197 | −4 834 | −261 |
| Net financials | 2 | 59 | 104 | 30 | 5 | 13 | 99 | 38 |
| Profit before tax | −962 | −1 205 | −1 429 | −1 671 | −1 614 | −1 184 | −4 735 | −222 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −962 | −1 205 | −1 429 | −1 671 | −1 614 | −1 184 | −4 735 | −222 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 1 350 | 10 542 | 10 975 | 7 451 | 6 290 | 3 331 | 2 544 | 1 654 |
| Equity | 1 093 | 9 099 | 7 669 | 5 998 | 4 384 | 2 609 | 1 874 | 1 652 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 257 | 1 443 | 3 306 | 1 453 | 1 906 | 722 | 670 | 2 |
| Total debt | 257 | 1 443 | 3 306 | 1 453 | 1 906 | 722 | 670 | 2 |
EBITDA margin
-20500800.0%
This company
15.8%
Market median
-129751999% vs market
20172024
Equity ratio
99.9%
This company
38.2%
Market median
+162% vs market
20172024
Return on equity
-13.4%
This company
18.4%
Market median
-173% vs market
20172024
Net profit margin
-22215700.0%
This company
8.1%
Market median
-274268001% vs market
20172024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20172024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20172024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-08 – 2017-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AB Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2018 | — | — | |
| Chairman | 2018 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2018 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Thor Medical Asa | Company | 100.0% | 100.0% | 2024 |
Scatec Innovation As | Company | 50.5% | 50.5% | 2022 |
Roht Invest As | Company | 13.4% | 13.4% | 2022 |
Bergfald Holding As | Company | 10.0% | 10.0% | 2022 |
Brennebu As | Company | 8.8% | 8.8% | 2022 |
| Individual | 7.0% | 7.0% | 2022 | |
Scatec Invest Ii As | Company | 1.6% | 1.6% | 2022 |
Optipos As | Company | 1.5% | 1.5% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Down Under As
TM TECHNOLOGIES AS Board members of TM TECHNOLOGIES AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Alf Bjørseth | Chief Executive Officer | 0 companies |
| Bård Gaute Bergfald | Board of Directors | 0 companies |
| John Andersen | Chairman | 0 companies |
| Brede Høyland Ellingsæter | Chairman | 0 companies |
| Jørn Aage Johansen | Board of Directors | 0 companies |